ArticleFrontiers in immunology2019

Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.

Marie-Pierre Piccinni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.